Order Article Reprints

Ramos E, Palomino-Antolín A, Bartolini M, Iriepa I, Moraleda I, Diez-Iriepa D, Samadi A, Cortina CV, Chioua M, Egea J, et al. QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer’s Disease Therapy. Molecules. 2019; 24(8):1503. https://doi.org/10.3390/molecules24081503

Ramos, Eva, Alejandra Palomino-Antolín, Manuela Bartolini, Isabel Iriepa, Ignacio Moraleda, Daniel Diez-Iriepa, Abdelouahid Samadi, Carol V. Cortina, Mourad Chioua, Javier Egea, and et al. 2019. "QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer’s Disease Therapy" Molecules 24, no. 8: 1503. https://doi.org/10.3390/molecules24081503

Ramos, E., Palomino-Antolín, A., Bartolini, M., Iriepa, I., Moraleda, I., Diez-Iriepa, D., Samadi, A., Cortina, C. V., Chioua, M., Egea, J., Romero, A., & Marco-Contelles, J. (2019). QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer’s Disease Therapy. Molecules, 24(8), 1503. https://doi.org/10.3390/molecules24081503